The coupled movements of sodium and chloride across the basolateral membrane of frog skin epithelium.
1. When frog skin epithelium was exposed to a chloride-free solution bathing the basolateral side of the frog skin preparation the short-circuit current fell and there was a simultaneous loss of chloride and water from its cells. This effect was partially blocked by furosemide when this drug was added to the basolateral bathing solution. 2. Under control conditions and when added to the solution bathing the basolateral side of the preparation furosemide had no effect on the ion and water contents of the frog skin epithelium. 3. Furosemide but not SITS (4-acetamide-4'-isothiocyanate-stilbene-2,2'-disulphonic acid) or amiloride blocked the recovery of short-circuit current and the reuptake of chloride and water by preparations pre-incubated with chloride-free solution on the basolateral side. The recovery of the short-circuit current was also blocked by the replacement of basolateral potassium by sodium. 4. The effect on the short-circuit current of graded replacements by impermeant ions of sodium or chloride did not show saturation for concentrations of these ions up to their control values. 5. Replacement of basolateral potassium by sodium inhibited the short-circuit current and the recovery observed when potassium was reintroduced in the basolateral bathing solution was blocked by furosemide. 6. The replacement of basolateral sodium or chloride by impermeant ions induced an immediate fall in the intracellular concentrations of both sodium and chloride suggesting that the transport system coupling the movements of the two ions across the basolateral membrane is operative under control conditions. 7. It is proposed that the coupled movements of sodium and chloride across the basolateral membrane of the frog skin epithelium are mediated by a sodium-potassium-2 chloride co-transport system which under control conditions is very near equilibrium.
Fernandes
P L
PL
Department of Cell Biology, Gulbenkian Institute of Science, Oeiras, Portugal.
Ferreira
H G
HG
Ferreira
K T
KT
D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D001693:Biological Transport, Active / Q000187:drug effects; D002712:Chlorides / Q000378:metabolism*; D004848:Epithelium / Q000378:metabolism; D005665:Furosemide / Q000494:pharmacology; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D011895:Rana ridibunda; D012867:Skin / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*
D001639:Bicarbonates; D002712:Chlorides; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; D000584:Amiloride; D005665:Furosemide; D012964:Sodium; D011188:Potassium